1007 related articles for article (PubMed ID: 22906963)
1. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
2. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
3. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
4. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
[TBL] [Abstract][Full Text] [Related]
5. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
[TBL] [Abstract][Full Text] [Related]
7. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
8. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590
[TBL] [Abstract][Full Text] [Related]
9. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Pinto AE; André S; Pereira T; Silva G; Soares J
Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
[TBL] [Abstract][Full Text] [Related]
10. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometry in primary breast carcinomas: prognostic impact of multiploidy and hypoploidy.
Michels JJ; Duigou F; Marnay J; Denoux Y; Delozier T; Chasle J
Cytometry B Clin Cytom; 2003 Sep; 55(1):37-45. PubMed ID: 12949958
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of DNA ploidy in breast cancer stage I-II.
Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
15. DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.
Buhmeida A; Algars A; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
Oncology; 2006; 70(6):427-37. PubMed ID: 17220640
[TBL] [Abstract][Full Text] [Related]
16. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]